Researchers found patients with pancreatic cancer and bowel cancer survived more than two years after receiving the vaccine

Non-mRNA jab targeting common mutations in pancreatic and bowel cancers could lower risk of relapse

Researchers found patients with pancreatic cancer and bowel cancer survived more than two years after receiving the vaccine